T058: Safety and Dose-Expansion Study of Combination Favezelimab (anti–LAG-3) Plus Pembrolizumab in Patients With Relapsed or Refractory Classical Hodgkin Lymphoma Refractory to Anti–PD-1 Treatment
| Autor: | John Timmerman, David Lavie, Nathalie A. Johnson, Abraham Avigdor, Peter Borchmann, Charalambos Andreadis, Ali Bazargan, Gareth Gregory, Colm Keane, Inna Tzoran, Vladan Vucinic, Pier Luigi Zinzani, Hong Zhang, Pallavi Pillai, Akash Nahar, Alex F. Herrera |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2022 |
| Předmět: | |
| Zdroj: | HemaSphere, Vol 6, Pp 27-27 (2022) |
| Druh dokumentu: | article |
| ISSN: | 2572-9241 |
| DOI: | 10.1097/01.HS9.0000890800.36906.bb |
| Databáze: | Directory of Open Access Journals |
| Externí odkaz: |
|
Plný text